ESR1 and breast cancer: It was not possible to directly demonstrate a high specificity of [18F]FES PET/CT compared with [18F]FDG PET/CT; however, the main concern was how the sensitivity of [18F]FES differs from that of [18F]FDG in patients with ER-positive primary breast cancer.